Laiprasert J D, Rogers R C, Heesch C M
Department of Physiology, Ohio State University, Columbus 43210-1218, USA.
Am J Physiol. 1998 Apr;274(4):R903-11. doi: 10.1152/ajpregu.1998.274.4.R903.
The major metabolite of progesterone, 3 alpha-OH-dihydroprogesterone (3 alpha-OH-DHP), is the most potent endogenous positive modulator of central nervous system GABAA receptors. Acute intravenous administration of 3 alpha-OH-DHP to virgin female rats potentiates arterial baroreflex sympathoinhibitory responses. The current experiments tested the possibility that circulating 3 alpha-OH-DHP potentiates central GABAergic influences in the rostral ventrolateral medulla (RVLM). The unit activity of spontaneously active, spinally projecting, and arterial pressure-sensitive neurons was recorded in the RVLM of urethan-anesthetized rats. Arterial pressure sensitivity of RVLM neurons was tested before (control) and 10 min after bolus injection (44 microliters i.v.) of 3 alpha-OH-DHP (1.12 micrograms/kg, n = 19) or vehicle (40% beta-cyclodextrin, n = 8). Both threshold pressure and saturation pressure for inhibition of RVLM neurons were decreased after acute administration of a physiological dose of 3 alpha-OH-DHP (1.12 micrograms/kg i.v.), which produces plasma concentrations similar to those seen during pregnancy (20-30 ng/ml), suggesting potentiated responsiveness to endogenously released GABA. Following suppression by 3 alpha-OH-DHP, high doses of the inactive stereoisomer 3 beta-OH-DHP (112-224 micrograms/kg i.v.; n = 8) restored unit activity, presumably by displacing 3 alpha-OH-DHP from the neurosteroid binding site on GABAA receptors.
孕酮的主要代谢产物3α-羟基二氢孕酮(3α-OH-DHP)是中枢神经系统GABAA受体最有效的内源性正向调节剂。给未交配的雌性大鼠急性静脉注射3α-OH-DHP可增强动脉压力反射交感抑制反应。当前实验测试了循环中的3α-OH-DHP增强延髓头端腹外侧区(RVLM)中枢GABA能影响的可能性。在乌拉坦麻醉大鼠的RVLM中记录自发活动、投射至脊髓且对动脉压敏感的神经元的单位活动。在推注注射(静脉注射44微升)3α-OH-DHP(1.12微克/千克,n = 19)或溶媒(40%β-环糊精,n = 8)之前(对照)和之后10分钟测试RVLM神经元的动脉压敏感性。急性给予生理剂量的3α-OH-DHP(静脉注射1.12微克/千克)后,抑制RVLM神经元的阈值压力和饱和压力均降低,该剂量产生的血浆浓度与孕期所见浓度相似(20 - 30纳克/毫升),提示对内源性释放的GABA反应性增强。在被3α-OH-DHP抑制后,高剂量的无活性立体异构体3β-OH-DHP(静脉注射112 - 224微克/千克;n = 8)恢复了单位活动,推测是通过将3α-OH-DHP从GABAA受体上的神经甾体结合位点置换下来实现的。